WO2007021990A3 - Melanocortin receptor-specific piperazine compounds with diamine groups - Google Patents
Melanocortin receptor-specific piperazine compounds with diamine groups Download PDFInfo
- Publication number
- WO2007021990A3 WO2007021990A3 PCT/US2006/031472 US2006031472W WO2007021990A3 WO 2007021990 A3 WO2007021990 A3 WO 2007021990A3 US 2006031472 W US2006031472 W US 2006031472W WO 2007021990 A3 WO2007021990 A3 WO 2007021990A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- melanocortin receptor
- agonist
- melanocortin
- diamine
- diamine groups
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nutrition Science (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Melanocortin receptor-specific compounds with diamine groups of the general formula (I) and pharmaceutically acceptable salts thereof, where W is a diamine heteroatom unit with at least one cationic center, hydrogen bond donor or hydrogen bond acceptor, J, Q, L1, L2, L3, R1a, R1b, R2a, R2b and X are as defined in the specification, and the carbon atom marked with an asterisk can have any stereochemical configuration. Compounds disclosed herein bind to one or more melanocortin receptors and may be an agonist, a partial agonist, an antagonist, an inverse agonist or an antagonist of an inverse agonist as to one or more melanocortin receptors, and may be employed for treatment of one or more melanocortin receptor-associated conditions or disorders, including specifically treatment of obesity and related conditions.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06813393A EP1922072A4 (en) | 2005-08-11 | 2006-08-11 | Melanocortin receptor-specific piperazine compounds with diamine groups |
JP2008526249A JP2009504671A (en) | 2005-08-11 | 2006-08-11 | Melanocortin receptor-specific piperazine compounds with diamine groups |
TW096126956A TW200817341A (en) | 2006-08-11 | 2007-07-24 | Diamine-containing, tetra-substituted piperazine compounds having identical 1-and 4-substituents |
ARP070103459A AR062219A1 (en) | 2006-08-11 | 2007-08-06 | TETRA- REPLACED PIPERAZINE COMPOUNDS CONTAINING DIAMINE AND HAVING 1 AND 4 IDENTICAL SUBSTITUTES |
US11/836,897 US7834017B2 (en) | 2006-08-11 | 2007-08-10 | Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents |
PCT/GB2007/003039 WO2008017852A1 (en) | 2006-08-11 | 2007-08-10 | Diamine-containing, tetra- substituted piperazine compounds as melanocortin receptor modulators |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70748805P | 2005-08-11 | 2005-08-11 | |
US60/707,488 | 2005-08-11 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/031474 Continuation-In-Part WO2007021991A2 (en) | 2005-08-11 | 2006-08-11 | Melanocortin receptor-specific piperazine and keto-piperazine compounds |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/464,069 Continuation-In-Part US7727990B2 (en) | 2003-05-01 | 2006-08-11 | Melanocortin receptor-specific piperazine and keto-piperazine compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007021990A2 WO2007021990A2 (en) | 2007-02-22 |
WO2007021990A3 true WO2007021990A3 (en) | 2007-08-09 |
Family
ID=37758229
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/031472 WO2007021990A2 (en) | 2005-08-11 | 2006-08-11 | Melanocortin receptor-specific piperazine compounds with diamine groups |
PCT/US2006/031474 WO2007021991A2 (en) | 2005-08-11 | 2006-08-11 | Melanocortin receptor-specific piperazine and keto-piperazine compounds |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/031474 WO2007021991A2 (en) | 2005-08-11 | 2006-08-11 | Melanocortin receptor-specific piperazine and keto-piperazine compounds |
Country Status (4)
Country | Link |
---|---|
EP (2) | EP1919479A4 (en) |
JP (2) | JP2009504671A (en) |
CN (2) | CN101272789A (en) |
WO (2) | WO2007021990A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7727991B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific single acyl piperazine compounds |
EP1919479A4 (en) * | 2005-08-11 | 2010-11-17 | Palatin Technologies Inc | Melanocortin receptor-specific piperazine and keto-piperazine compounds |
WO2008090357A2 (en) * | 2007-01-24 | 2008-07-31 | Palatin Technologies, Inc. | N, n; -substituted piperazines binding to melanocortin receptor |
WO2009144432A1 (en) * | 2008-05-30 | 2009-12-03 | Palatin Technologies, Inc. | Mc4-r agonists for the treatment of obesity |
WO2017090743A1 (en) * | 2015-11-27 | 2017-06-01 | 田辺三菱製薬株式会社 | Novel imidazole compound and use thereof as melanocortin receptor agonist |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040204398A1 (en) * | 2003-03-03 | 2004-10-14 | Bakshi Raman K. | Acylated piperazine derivatives as melanocortin-4 receptor agonists |
US20040224957A1 (en) * | 2003-05-01 | 2004-11-11 | Palatin Technologies, Inc. | Melanocortin receptor-specific compounds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7732451B2 (en) * | 2001-08-10 | 2010-06-08 | Palatin Technologies, Inc. | Naphthalene-containing melanocortin receptor-specific small molecule |
US7354923B2 (en) * | 2001-08-10 | 2008-04-08 | Palatin Technologies, Inc. | Piperazine melanocortin-specific compounds |
EP1919479A4 (en) * | 2005-08-11 | 2010-11-17 | Palatin Technologies Inc | Melanocortin receptor-specific piperazine and keto-piperazine compounds |
-
2006
- 2006-08-11 EP EP06813394A patent/EP1919479A4/en not_active Withdrawn
- 2006-08-11 WO PCT/US2006/031472 patent/WO2007021990A2/en active Application Filing
- 2006-08-11 JP JP2008526249A patent/JP2009504671A/en active Pending
- 2006-08-11 JP JP2008526250A patent/JP2009504672A/en active Pending
- 2006-08-11 CN CNA2006800353810A patent/CN101272789A/en active Pending
- 2006-08-11 WO PCT/US2006/031474 patent/WO2007021991A2/en active Application Filing
- 2006-08-11 EP EP06813393A patent/EP1922072A4/en not_active Withdrawn
- 2006-08-11 CN CNA2006800353276A patent/CN101272788A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040204398A1 (en) * | 2003-03-03 | 2004-10-14 | Bakshi Raman K. | Acylated piperazine derivatives as melanocortin-4 receptor agonists |
US20040224957A1 (en) * | 2003-05-01 | 2004-11-11 | Palatin Technologies, Inc. | Melanocortin receptor-specific compounds |
Non-Patent Citations (1)
Title |
---|
See also references of EP1922072A4 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007021991A2 (en) | 2007-02-22 |
CN101272789A (en) | 2008-09-24 |
WO2007021991A3 (en) | 2007-07-12 |
JP2009504672A (en) | 2009-02-05 |
EP1922072A4 (en) | 2010-12-29 |
CN101272788A (en) | 2008-09-24 |
JP2009504671A (en) | 2009-02-05 |
EP1922072A2 (en) | 2008-05-21 |
WO2007021990A2 (en) | 2007-02-22 |
EP1919479A2 (en) | 2008-05-14 |
EP1919479A4 (en) | 2010-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE390922T1 (en) | 2-AMINOBENZOTHIAZOLE AS A CB1 RECEPTOR INVERSE AGONIST | |
MXPA05011729A (en) | Melanocortin receptor-specific compounds. | |
SI2114933T1 (en) | Piperidine gpcr agonists | |
NO20080052L (en) | G-Protein Coupled Receptor Agonists | |
WO2007021990A3 (en) | Melanocortin receptor-specific piperazine compounds with diamine groups | |
WO2007116229A8 (en) | Heterocyclic gpcr agonists | |
MX2007004794A (en) | Thienopyridines as allosteric potentiators of the m4 muscarinic receptor. | |
SG154443A1 (en) | Piperidine derivatives as nk1 antagonists | |
NO20080010L (en) | GPCR agonists | |
ATE435862T1 (en) | AZABICYCLOALKAN COMPOUNDS AS MUSCARINE RECEPTOR ANTAGONISTS | |
NO20082136L (en) | 1,5-substituted indol-2-yl amide derivatives | |
ES2318577T3 (en) | DERIVATIVES OF CYCLALKYL LACTAMA AS INHIBITORS OF 11-BETA-HYDROXIESTEROID DEHYDROGENASE 1 '. | |
MY148487A (en) | Biphenyl derivatives | |
NO20082939L (en) | Cyclohexyl piperasinyl methanone derivatives and their use as histamine H3 receptor modulators | |
WO2006066173A3 (en) | Novel mch receptor antagonists | |
WO2008096820A1 (en) | Biphenyl derivative | |
WO2007124254A3 (en) | Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 | |
IL191629A0 (en) | Tricyclic amide derivatives useful for treating obesity | |
MY155212A (en) | Quaternary ammonium salt compounds | |
IL201317A0 (en) | Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists | |
MX2010006230A (en) | Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists. | |
ATE478856T1 (en) | SPIROBENZODIOXOLS AND THEIR USE AS CB1 ANTAGONISTS | |
MX2009010552A (en) | Peripheral opioid receptor antagonists and uses thereof. | |
WO2009057784A1 (en) | Heterocyclic compound | |
MX2009004314A (en) | Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680035327.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2008526249 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1364/DELNP/2008 Country of ref document: IN Ref document number: 2006813393 Country of ref document: EP |